HEADER TRANSFERASE 19-OCT-07 3B2W TITLE CRYSTAL STRUCTURE OF PYRIMIDINE AMIDE 11 BOUND TO LCK COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTO-ONCOGENE TYROSINE-PROTEIN KINASE LCK; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: LCK KINASE DOMAIN: RESIDUES 226-502; COMPND 5 SYNONYM: P56-LCK, LYMPHOCYTE CELL-SPECIFIC PROTEIN-TYROSINE KINASE, COMPND 6 LSK, T CELL-SPECIFIC PROTEIN-TYROSINE KINASE; COMPND 7 EC: 2.7.10.2; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: LCK; SOURCE 6 EXPRESSION_SYSTEM: UNIDENTIFIED BACULOVIRUS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 10469; SOURCE 8 EXPRESSION_SYSTEM_COLLECTION: INSECT CELL KEYWDS LCK, KINASE DOMAIN, ALTERNATIVE SPLICING, ATP-BINDING, CHROMOSOMAL KEYWDS 2 REARRANGEMENT, CYTOPLASM, DISEASE MUTATION, HOST-VIRUS INTERACTION, KEYWDS 3 LIPOPROTEIN, MEMBRANE, MYRISTATE, NUCLEOTIDE-BINDING, PALMITATE, KEYWDS 4 PHOSPHORYLATION, PROTO-ONCOGENE, SH2 DOMAIN, SH3 DOMAIN, KEYWDS 5 TRANSFERASE, TYROSINE-PROTEIN KINASE EXPDTA X-RAY DIFFRACTION AUTHOR X.HUANG REVDAT 4 30-AUG-23 3B2W 1 REMARK REVDAT 3 24-FEB-09 3B2W 1 VERSN REVDAT 2 19-FEB-08 3B2W 1 JRNL REVDAT 1 18-DEC-07 3B2W 0 JRNL AUTH H.L.DEAK,J.R.NEWCOMB,J.J.NUNES,C.BOUCHER,A.C.CHENG, JRNL AUTH 2 E.F.DIMAURO,L.F.EPSTEIN,P.GALLANT,B.L.HODOUS,X.HUANG, JRNL AUTH 3 J.H.LEE,V.F.PATEL,S.SCHNEIDER,S.M.TURCI,X.ZHU JRNL TITL N-(3-(PHENYLCARBAMOYL)ARYLPYRIMIDINE)-5-CARBOXAMIDES AS JRNL TITL 2 POTENT AND SELECTIVE INHIBITORS OF LCK: STRUCTURE, SYNTHESIS JRNL TITL 3 AND SAR. JRNL REF BIOORG.MED.CHEM.LETT. V. 18 1172 2008 JRNL REFN ISSN 0960-894X JRNL PMID 18083554 JRNL DOI 10.1016/J.BMCL.2007.11.123 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 12320 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.230 REMARK 3 FREE R VALUE : 0.308 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2068 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 45 REMARK 3 SOLVENT ATOMS : 135 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.011 REMARK 3 BOND ANGLES (DEGREES) : 1.500 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3B2W COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-OCT-07. REMARK 100 THE DEPOSITION ID IS D_1000045010. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12320 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.3 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.07800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 81.6 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.28800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1QPC REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.72 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.31 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.0 M LICL, 20% PEG 6000, PH 6.0, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 37.59500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 226 REMARK 465 GLN A 227 REMARK 465 LYS A 228 REMARK 465 PRO A 229 REMARK 465 GLN A 230 REMARK 465 LYS A 231 REMARK 465 PRO A 232 REMARK 465 TRP A 233 REMARK 465 TRP A 234 REMARK 465 GLU A 235 REMARK 465 ASP A 236 REMARK 465 GLU A 237 REMARK 465 ARG A 397 REMARK 465 GLU A 398 REMARK 465 THR A 501 REMARK 465 GLU A 502 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 255 CG CD OE1 NE2 REMARK 470 GLN A 277 CG CD OE1 NE2 REMARK 470 ASP A 283 CG OD1 OD2 REMARK 470 GLN A 309 CG CD OE1 NE2 REMARK 470 GLU A 310 CG CD OE1 OE2 REMARK 470 ARG A 387 CG CD NE CZ NH1 NH2 REMARK 470 TYR A 394 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS A 401 CG CD CE NZ REMARK 470 GLN A 451 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE2 GLU A 356 O HOH A 656 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 248 -44.79 -135.89 REMARK 500 THR A 308 30.32 -98.44 REMARK 500 ARG A 363 -15.17 86.44 REMARK 500 ASP A 364 50.00 -148.03 REMARK 500 ASP A 382 87.79 30.22 REMARK 500 ASN A 392 -162.70 -177.47 REMARK 500 TYR A 394 -86.50 134.29 REMARK 500 REMARK 500 REMARK: NULL REMARK 615 REMARK 615 ZERO OCCUPANCY ATOM REMARK 615 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 615 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 615 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 615 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 615 M RES C SSEQI REMARK 615 HOH A 642 REMARK 615 HOH A 667 REMARK 615 HOH A 686 REMARK 615 HOH A 695 REMARK 615 HOH A 726 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 9NH A 601 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2OFV RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AMINOQUINAZOLINE 1 BOUND TO LCK DBREF 3B2W A 226 502 UNP P06239 LCK_HUMAN 226 502 SEQRES 1 A 277 THR GLN LYS PRO GLN LYS PRO TRP TRP GLU ASP GLU TRP SEQRES 2 A 277 GLU VAL PRO ARG GLU THR LEU LYS LEU VAL GLU ARG LEU SEQRES 3 A 277 GLY ALA GLY GLN PHE GLY GLU VAL TRP MET GLY TYR TYR SEQRES 4 A 277 ASN GLY HIS THR LYS VAL ALA VAL LYS SER LEU LYS GLN SEQRES 5 A 277 GLY SER MET SER PRO ASP ALA PHE LEU ALA GLU ALA ASN SEQRES 6 A 277 LEU MET LYS GLN LEU GLN HIS GLN ARG LEU VAL ARG LEU SEQRES 7 A 277 TYR ALA VAL VAL THR GLN GLU PRO ILE TYR ILE ILE THR SEQRES 8 A 277 GLU TYR MET GLU ASN GLY SER LEU VAL ASP PHE LEU LYS SEQRES 9 A 277 THR PRO SER GLY ILE LYS LEU THR ILE ASN LYS LEU LEU SEQRES 10 A 277 ASP MET ALA ALA GLN ILE ALA GLU GLY MET ALA PHE ILE SEQRES 11 A 277 GLU GLU ARG ASN TYR ILE HIS ARG ASP LEU ARG ALA ALA SEQRES 12 A 277 ASN ILE LEU VAL SER ASP THR LEU SER CYS LYS ILE ALA SEQRES 13 A 277 ASP PHE GLY LEU ALA ARG LEU ILE GLU ASP ASN GLU TYR SEQRES 14 A 277 THR ALA ARG GLU GLY ALA LYS PHE PRO ILE LYS TRP THR SEQRES 15 A 277 ALA PRO GLU ALA ILE ASN TYR GLY THR PHE THR ILE LYS SEQRES 16 A 277 SER ASP VAL TRP SER PHE GLY ILE LEU LEU THR GLU ILE SEQRES 17 A 277 VAL THR HIS GLY ARG ILE PRO TYR PRO GLY MET THR ASN SEQRES 18 A 277 PRO GLU VAL ILE GLN ASN LEU GLU ARG GLY TYR ARG MET SEQRES 19 A 277 VAL ARG PRO ASP ASN CYS PRO GLU GLU LEU TYR GLN LEU SEQRES 20 A 277 MET ARG LEU CYS TRP LYS GLU ARG PRO GLU ASP ARG PRO SEQRES 21 A 277 THR PHE ASP TYR LEU ARG SER VAL LEU GLU ASP PHE PHE SEQRES 22 A 277 THR ALA THR GLU HET 9NH A 601 45 HETNAM 9NH N-[5-({[2-FLUORO-3-(TRIFLUOROMETHYL) HETNAM 2 9NH PHENYL]AMINO}CARBONYL)-2-METHYLPHENYL]-4-METHOXY-2- HETNAM 3 9NH [(4-PIPERAZIN-1-YLPHENYL)AMINO]PYRIMIDINE-5- HETNAM 4 9NH CARBOXAMIDE FORMUL 2 9NH C31 H29 F4 N7 O3 FORMUL 3 HOH *135(H2 O) HELIX 1 1 PRO A 241 GLU A 243 5 3 HELIX 2 2 SER A 281 LEU A 295 1 15 HELIX 3 3 SER A 323 LEU A 328 1 6 HELIX 4 4 THR A 330 LEU A 336 1 7 HELIX 5 5 THR A 337 ARG A 358 1 22 HELIX 6 6 ARG A 366 ALA A 368 5 3 HELIX 7 7 LEU A 385 GLU A 390 1 6 HELIX 8 8 PRO A 403 THR A 407 5 5 HELIX 9 9 ALA A 408 GLY A 415 1 8 HELIX 10 10 THR A 418 THR A 435 1 18 HELIX 11 11 THR A 445 ARG A 455 1 11 HELIX 12 12 PRO A 466 TRP A 477 1 12 HELIX 13 13 ARG A 480 ARG A 484 5 5 HELIX 14 14 THR A 486 THR A 499 1 14 SHEET 1 A 5 LEU A 245 GLY A 254 0 SHEET 2 A 5 GLY A 257 TYR A 264 -1 O VAL A 259 N LEU A 251 SHEET 3 A 5 THR A 268 LEU A 275 -1 O VAL A 272 N TRP A 260 SHEET 4 A 5 TYR A 313 GLU A 317 -1 O THR A 316 N ALA A 271 SHEET 5 A 5 LEU A 303 VAL A 307 -1 N ALA A 305 O ILE A 315 SHEET 1 B 2 ILE A 370 VAL A 372 0 SHEET 2 B 2 CYS A 378 ILE A 380 -1 O LYS A 379 N LEU A 371 CISPEP 1 GLU A 310 PRO A 311 0 -0.05 SITE 1 AC1 18 VAL A 259 ALA A 271 LYS A 273 GLU A 288 SITE 2 AC1 18 MET A 292 LEU A 300 VAL A 301 ILE A 314 SITE 3 AC1 18 THR A 316 GLU A 317 TYR A 318 MET A 319 SITE 4 AC1 18 GLY A 322 LEU A 371 ILE A 380 ALA A 381 SITE 5 AC1 18 ASP A 382 PHE A 383 CRYST1 45.180 75.190 47.110 90.00 112.35 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022134 0.000000 0.009100 0.00000 SCALE2 0.000000 0.013300 0.000000 0.00000 SCALE3 0.000000 0.000000 0.022951 0.00000